KR101500191B1 - 피부 케어용 조성물 및 이의 제조 방법 - Google Patents
피부 케어용 조성물 및 이의 제조 방법 Download PDFInfo
- Publication number
- KR101500191B1 KR101500191B1 KR20130137232A KR20130137232A KR101500191B1 KR 101500191 B1 KR101500191 B1 KR 101500191B1 KR 20130137232 A KR20130137232 A KR 20130137232A KR 20130137232 A KR20130137232 A KR 20130137232A KR 101500191 B1 KR101500191 B1 KR 101500191B1
- Authority
- KR
- South Korea
- Prior art keywords
- skin
- oil
- composition
- weight
- skin care
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 57
- 238000000034 method Methods 0.000 title claims abstract description 13
- 238000004519 manufacturing process Methods 0.000 title claims description 8
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 12
- 239000003921 oil Substances 0.000 claims description 44
- 238000000855 fermentation Methods 0.000 claims description 19
- 230000004151 fermentation Effects 0.000 claims description 19
- 239000004475 Arginine Substances 0.000 claims description 13
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 13
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 10
- 244000125300 Argania sideroxylon Species 0.000 claims description 10
- 229920002125 Sokalan® Polymers 0.000 claims description 10
- 229960001631 carbomer Drugs 0.000 claims description 10
- 239000012153 distilled water Substances 0.000 claims description 10
- 239000000230 xanthan gum Substances 0.000 claims description 10
- 229920001285 xanthan gum Polymers 0.000 claims description 10
- 229940082509 xanthan gum Drugs 0.000 claims description 10
- 235000010493 xanthan gum Nutrition 0.000 claims description 10
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 claims description 8
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 7
- 235000006679 Mentha X verticillata Nutrition 0.000 claims description 7
- 235000002899 Mentha suaveolens Nutrition 0.000 claims description 7
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- 229940098465 tincture Drugs 0.000 claims description 7
- 239000000787 lecithin Substances 0.000 claims description 5
- 235000010445 lecithin Nutrition 0.000 claims description 5
- 229940067606 lecithin Drugs 0.000 claims description 5
- 239000010667 rosehip oil Substances 0.000 claims description 5
- UXDDRFCJKNROTO-UHFFFAOYSA-N Glycerol 1,2-diacetate Chemical compound CC(=O)OCC(CO)OC(C)=O UXDDRFCJKNROTO-UHFFFAOYSA-N 0.000 claims description 4
- 239000004348 Glyceryl diacetate Substances 0.000 claims description 4
- 241000220317 Rosa Species 0.000 claims description 4
- 235000019443 glyceryl diacetate Nutrition 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 230000032683 aging Effects 0.000 claims description 3
- 238000004090 dissolution Methods 0.000 claims description 2
- 235000019198 oils Nutrition 0.000 abstract description 36
- 206010015150 Erythema Diseases 0.000 abstract description 10
- 239000000686 essence Substances 0.000 abstract description 10
- 239000006210 lotion Substances 0.000 abstract description 10
- 239000002537 cosmetic Substances 0.000 abstract description 9
- 206010013786 Dry skin Diseases 0.000 abstract description 5
- 230000037336 dry skin Effects 0.000 abstract description 5
- 208000003251 Pruritus Diseases 0.000 abstract description 4
- 230000036560 skin regeneration Effects 0.000 abstract description 4
- 238000011282 treatment Methods 0.000 abstract description 4
- 235000016108 Argania sideroxylon Nutrition 0.000 abstract description 2
- 244000025254 Cannabis sativa Species 0.000 abstract description 2
- 235000008697 Cannabis sativa Nutrition 0.000 abstract description 2
- 235000000539 Rosa canina Nutrition 0.000 abstract description 2
- 240000008530 Rosa canina Species 0.000 abstract description 2
- 238000013532 laser treatment Methods 0.000 abstract description 2
- 239000006166 lysate Substances 0.000 abstract description 2
- 230000008929 regeneration Effects 0.000 abstract description 2
- 238000011069 regeneration method Methods 0.000 abstract description 2
- 208000017520 skin disease Diseases 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 abstract 5
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 abstract 1
- 241001673902 Argania spinosa Species 0.000 abstract 1
- 206010039580 Scar Diseases 0.000 abstract 1
- 210000002615 epidermis Anatomy 0.000 abstract 1
- 239000013589 supplement Substances 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 41
- 231100000321 erythema Toxicity 0.000 description 9
- 239000007933 dermal patch Substances 0.000 description 8
- 230000003020 moisturizing effect Effects 0.000 description 8
- 231100000430 skin reaction Toxicity 0.000 description 8
- 239000004094 surface-active agent Substances 0.000 description 6
- 206010040880 Skin irritation Diseases 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 231100000475 skin irritation Toxicity 0.000 description 5
- 230000036556 skin irritation Effects 0.000 description 5
- 229940015975 1,2-hexanediol Drugs 0.000 description 4
- ASKIVFGGGGIGKH-UHFFFAOYSA-N 2,3-dihydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 description 4
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 230000003750 conditioning effect Effects 0.000 description 4
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 4
- 229960005323 phenoxyethanol Drugs 0.000 description 4
- 230000000638 stimulation Effects 0.000 description 4
- 206010012442 Dermatitis contact Diseases 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 229960003121 arginine Drugs 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 208000010247 contact dermatitis Diseases 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- 230000007803 itching Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 201000004681 Psoriasis Diseases 0.000 description 2
- 206010040914 Skin reaction Diseases 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 229940074052 glyceryl isostearate Drugs 0.000 description 2
- 239000000944 linseed oil Substances 0.000 description 2
- 235000021388 linseed oil Nutrition 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 239000011369 resultant mixture Substances 0.000 description 2
- 238000011076 safety test Methods 0.000 description 2
- 210000004761 scalp Anatomy 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 206010040882 skin lesion Diseases 0.000 description 2
- 231100000444 skin lesion Toxicity 0.000 description 2
- 230000035483 skin reaction Effects 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- AILDTIZEPVHXBF-UHFFFAOYSA-N Argentine Natural products C1C(C2)C3=CC=CC(=O)N3CC1CN2C(=O)N1CC(C=2N(C(=O)C=CC=2)C2)CC2C1 AILDTIZEPVHXBF-UHFFFAOYSA-N 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 208000022535 Infectious Skin disease Diseases 0.000 description 1
- 125000002066 L-histidyl group Chemical group [H]N1C([H])=NC(C([H])([H])[C@](C(=O)[*])([H])N([H])[H])=C1[H] 0.000 description 1
- 206010033733 Papule Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- -1 Polyoxyethylene Glyceryl Monostearate Polymers 0.000 description 1
- 235000016594 Potentilla anserina Nutrition 0.000 description 1
- 244000308495 Potentilla anserina Species 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- 239000004902 Softening Agent Substances 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 208000002352 blister Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003433 contraceptive agent Substances 0.000 description 1
- 230000002254 contraceptive effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229940124595 oriental medicine Drugs 0.000 description 1
- 208000021090 palsy Diseases 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000018040 scab formation Effects 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
Abstract
본 발명에 따르면, 박피 시술 후 진정 관리, 여드름 피부 박피, 레이저 시술 후 진정 관리 등과 같이 스트레스로 인한 피부나 가려움증이 있는 피부를 진정 케어할 수 있고, 피부의 부드러움과 보습을 더해주어 피부 보습을 관리할 수 있으며, 붉은 기운, 피부 재생 및 즉각적인 유수분 보충 등에 의해 약건성 피부를 관리할 수 있고, 에센스나 로션의 화장품 조성물로 사용이 가능하며, 피부재생 관리 트리트먼트용으로서 초음파 기기 관리용으로 사용될 수 있다.
Description
Claims (5)
- 피부 케어를 위한 조성물에 있어서,
비피다 발효 용해물, 아르간 트리커넬 오일, 마인 오일, 로즈힙 열매 오일이 포함되는 것을 특징으로 하는 피부 케어용 조성물. - 청구항 1에 있어서,
상기 비피다 발효 용해물, 상기 아르간 트리커넬 오일, 상기 마인 오일 및 상기 로즈힙 열매 오일은,
상기 조성물의 총 중량에 대하여, 85~95중량%, 2~6중량%, 0.5~2.0중량% 및 0.05~0.2중량% 포함되는 것을 특징으로 하는 피부 케어용 조성물. - 청구항 1에 있어서,
상기 비피다 발효 용해물, 상기 아르간 트리커넬 오일, 상기 마인 오일 및 상기 로즈힙 열매 오일을 제외한 나머지 조성물은,
PEG-15글리세릴이소스테아레이트, 하이드로제네이티드레시틴, 알지닌, 카보머, 잔탄검 및 증류수가 포함되는 것을 특징으로 하는 피부 케어용 조성물. - 피부 케어를 위한 조성물을 제조하는 방법에 있어서,
증류수에 잔탄검과 카보머를 40~50℃에서 용해시키는 단계;
상기 용해의 결과물에 아르간 트리커넬 오일, 마인 오일 및 로즈힙 오일을 배합하는 단계:
상기 배합의 결과물에 PEG-15글리세릴이소스테아레이트를 혼합하는 단계;
상기 혼합의 결과물을 25~35℃에서 비피다 발효 용해물, 하이드로제네이티드레시틴 및 알지닌을 첨가하여 교반하는 단계; 및
상기 교반의 결과물을 실온에서 2~4일간 숙성시키는 단계를 포함하고,
상기 비피다 발효 용해물, 상기 아르간 트리커넬 오일, 상기 마인 오일 및 상기 로즈힙 열매 오일은,
상기 조성물의 총 중량에 대하여, 85~95중량%, 2~6중량%, 0.5~2.0중량% 및 0.05~0.2중량% 포함되는 것을 특징으로 하는 피부 케어용 조성물의 제조 방법. - 청구항 4에 있어서,
상기 PEG-15글리세릴이소스테아레이트, 상기 하이드로제네이티드레시틴, 상기 알지닌, 상기 카보머, 상기 잔탄검 및 상기 증류수는,
1 : 0.5~2.0 : 0.5~2.0 : 0.5~2.0 : 0.5~2.0 : 0.5~2.0의 중량 비율로 상기 조성물에 포함되는 것을 특징으로 하는 피부 케어용 조성물의 제조 방법.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20130137232A KR101500191B1 (ko) | 2013-11-12 | 2013-11-12 | 피부 케어용 조성물 및 이의 제조 방법 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20130137232A KR101500191B1 (ko) | 2013-11-12 | 2013-11-12 | 피부 케어용 조성물 및 이의 제조 방법 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR101500191B1 true KR101500191B1 (ko) | 2015-03-09 |
Family
ID=53026735
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR20130137232A Active KR101500191B1 (ko) | 2013-11-12 | 2013-11-12 | 피부 케어용 조성물 및 이의 제조 방법 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101500191B1 (ko) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101611134B1 (ko) | 2015-06-16 | 2016-04-08 | 하승완 | 피부 재생용 화장품의 제조방법 |
CN107349157A (zh) * | 2017-09-06 | 2017-11-17 | 云南汉木森生物科技有限责任公司 | 含火麻叶提取物的祛斑抗皱雪花膏及其制备方法 |
CN107536797A (zh) * | 2017-10-23 | 2018-01-05 | 广西巴马响泉食品有限公司 | 一种火麻蜜 |
CN107811904A (zh) * | 2017-10-27 | 2018-03-20 | 云南汉木森生物科技有限责任公司 | 抗炎祛斑雪花膏及其制备方法 |
WO2020021544A1 (en) * | 2018-07-25 | 2020-01-30 | Bol Pharma Ltd. | Cannabidiol and methylthio-butyl-isothiocyanate for treating inflammatory diseases |
CN111991336A (zh) * | 2020-09-04 | 2020-11-27 | 北京瑞济善健康科技有限公司 | 一种多效凝胶精华及其制备方法与应用 |
CN113604509A (zh) * | 2021-08-26 | 2021-11-05 | 山东朵拉朵尚生物科技有限公司 | 二裂酵母发酵产物及其制备方法和用途 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20090041886A (ko) * | 2007-10-25 | 2009-04-29 | 유한킴벌리 주식회사 | 식물성 3중 보습 성분 및 이를 포함하는 스킨 케어 조성물 |
WO2010124280A2 (en) * | 2009-04-24 | 2010-10-28 | New Century Pharmaceuticals, Inc. | Human serum albumin-based topical ointment for treatment of acne, psoriasis, egfr-induced toxicity, premature skin aging and other skin conditions |
KR20120024822A (ko) * | 2009-06-23 | 2012-03-14 | 이엘씨 매니지먼트 엘엘씨 | 일주기 유전자 활성자 및 sirt1 유전자 활성자들의 상승작용적 조합물을 포함하는 피부 복구 조성물 |
KR20130039058A (ko) * | 2011-10-11 | 2013-04-19 | 주식회사 제닉 | 에멀젼화된 하이드로겔 조성물 및 이의 제조방법 |
-
2013
- 2013-11-12 KR KR20130137232A patent/KR101500191B1/ko active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20090041886A (ko) * | 2007-10-25 | 2009-04-29 | 유한킴벌리 주식회사 | 식물성 3중 보습 성분 및 이를 포함하는 스킨 케어 조성물 |
WO2010124280A2 (en) * | 2009-04-24 | 2010-10-28 | New Century Pharmaceuticals, Inc. | Human serum albumin-based topical ointment for treatment of acne, psoriasis, egfr-induced toxicity, premature skin aging and other skin conditions |
KR20120024822A (ko) * | 2009-06-23 | 2012-03-14 | 이엘씨 매니지먼트 엘엘씨 | 일주기 유전자 활성자 및 sirt1 유전자 활성자들의 상승작용적 조합물을 포함하는 피부 복구 조성물 |
KR20130039058A (ko) * | 2011-10-11 | 2013-04-19 | 주식회사 제닉 | 에멀젼화된 하이드로겔 조성물 및 이의 제조방법 |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101611134B1 (ko) | 2015-06-16 | 2016-04-08 | 하승완 | 피부 재생용 화장품의 제조방법 |
CN107349157A (zh) * | 2017-09-06 | 2017-11-17 | 云南汉木森生物科技有限责任公司 | 含火麻叶提取物的祛斑抗皱雪花膏及其制备方法 |
CN107536797A (zh) * | 2017-10-23 | 2018-01-05 | 广西巴马响泉食品有限公司 | 一种火麻蜜 |
CN107811904A (zh) * | 2017-10-27 | 2018-03-20 | 云南汉木森生物科技有限责任公司 | 抗炎祛斑雪花膏及其制备方法 |
CN107811904B (zh) * | 2017-10-27 | 2020-07-14 | 云南汉木森生物科技有限责任公司 | 抗炎祛斑雪花膏及其制备方法 |
WO2020021544A1 (en) * | 2018-07-25 | 2020-01-30 | Bol Pharma Ltd. | Cannabidiol and methylthio-butyl-isothiocyanate for treating inflammatory diseases |
CN111991336A (zh) * | 2020-09-04 | 2020-11-27 | 北京瑞济善健康科技有限公司 | 一种多效凝胶精华及其制备方法与应用 |
CN113604509A (zh) * | 2021-08-26 | 2021-11-05 | 山东朵拉朵尚生物科技有限公司 | 二裂酵母发酵产物及其制备方法和用途 |
CN113604509B (zh) * | 2021-08-26 | 2023-08-11 | 山东朵拉朵尚生物科技有限公司 | 二裂酵母发酵产物及其制备方法和用途 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101500191B1 (ko) | 피부 케어용 조성물 및 이의 제조 방법 | |
CN109846757B (zh) | 一种皮脂仿生组合物及包含其的化妆品 | |
CN101869539B (zh) | 一种用于敏感性皮肤修复的脱敏复合纳米乳及其制备方法 | |
US9078838B2 (en) | Cosmetic or dermatological compositions comprising a mixture of essential oils, and its uses thereof, particularly for the care of sensitive or sensitized skin | |
US10004678B2 (en) | Anti-dandruff compositions, and methods of use thereof | |
TW202228748A (zh) | 用於在敏感性皮膚正常化皮膚微生物群之方法與組成物 | |
TWI671080B (zh) | 摻混神經醯胺之外用劑組成物 | |
Tanuwidjaja | Development of Anti-Aging Cream Preparations with Active Substances from Plant Extracts: Physicochemical Review and Potential Applications | |
KR20210073265A (ko) | 상온 유화 공정을 이용한 아토피 개선 로션 | |
KR20170010499A (ko) | 달팽이 점액 발효여과물을 유효성분으로 하는 피부장벽 개선 및 높은 피부 흡수율을 갖는 화장료 조성물과 기능성 화장품 | |
FR2892302A1 (fr) | Nouvelles applications hydratantes et anti-age d'un substitut de lanoline 100% vegetal, et compositions adaptees le contenant | |
JP2007008912A (ja) | 生活リズム恒常性維持のための美容施術方法 | |
Matysiak et al. | STUDIES ON THE FORMULATION AND FUNCTIONALITY OF AN INNOVATIVE LINE OF TOPICAL PRODUCTS FOR ATOPIC SKIN. | |
Craveiro | Skin-Friendly Oncosmetics–Specific Cosmetics for People Undergoing Cancer Treatment | |
Thool | DEVELOPMENT AND EVALUATION OF TOPICAL PREPARATION TO RESTORE DRY SKIN | |
KR20140081967A (ko) | 청삼 종실유를 함유한 아토피 피부 개선 기능성 화장품 조성물 | |
JP2024504628A (ja) | カンナビジオール及びブロッコリー種子油を含有する組成物、並びにそのような組成物の作製方法及び使用方法 | |
Adejokun | Design of a novel anti-cellulite treatment, an evidence based approach | |
US10751274B1 (en) | Fast-acting micelle nanoparticle and cosmetic composition comprising same | |
Cherkasova et al. | Development of the composition of the balm-mask for treatment application seboreic dermatitis of the scalp | |
Garrós Aristizábal | Liposome Study of Baricitinib as a Novel Formula for Topical Treatment of Autoimmune Diseases | |
Nunse et al. | Cream as a Drug Delivery System for Topical Diseases | |
CN119908980A (zh) | 一种护肤乳液 | |
Nunse et al. | Cream as a Drug Delivery System | |
CN116549318A (zh) | 含棕榈酰寡肽的以油养肤组合物及应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20131112 |
|
PA0201 | Request for examination | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20150107 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20150302 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20150302 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
FPAY | Annual fee payment |
Payment date: 20180301 Year of fee payment: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20180301 Start annual number: 4 End annual number: 4 |
|
FPAY | Annual fee payment |
Payment date: 20190221 Year of fee payment: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20190221 Start annual number: 5 End annual number: 5 |
|
FPAY | Annual fee payment |
Payment date: 20200204 Year of fee payment: 6 |
|
PR1001 | Payment of annual fee |
Payment date: 20200204 Start annual number: 6 End annual number: 6 |
|
PR1001 | Payment of annual fee |
Payment date: 20210218 Start annual number: 7 End annual number: 7 |
|
PR1001 | Payment of annual fee |
Payment date: 20230221 Start annual number: 9 End annual number: 9 |
|
PR1001 | Payment of annual fee |
Payment date: 20250305 Start annual number: 11 End annual number: 11 |